A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection
- 8 November 2005
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 229 (1) , 77-83
- https://doi.org/10.1016/j.canlet.2005.04.014
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Codon 72 polymorphism of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patientsCancer Letters, 2004
- Influences of lifestyle habits and p53 codon 72 and p21 codon 31 polymorphisms on gastric cancer risk in TaiwanCancer Letters, 2004
- p14ARF gene alterations in human hepatocellular carcinomaEuropean Journal of Gastroenterology & Hepatology, 2004
- Polymorphisms in XRCC1 and Glutathione S-Transferase Genes and Hepatitis B-Related Hepatocellular CarcinomaJNCI Journal of the National Cancer Institute, 2003
- The codon 72 polymorphic variants of p53 have markedly different apoptotic potentialNature Genetics, 2003
- p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori‐associated chronic gastritisInternational Journal of Cancer, 2002
- Prognostic Significance of the Proline Form of p53 Codon 72 Polymorphism in Nasopharyngeal CarcinomaThe Laryngoscope, 2002
- p53 codon 72 polymorphism and human papillomavirus associated skin cancerJournal of Clinical Pathology, 2001
- Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on riskGut, 2000
- Genetics of hepatocellular carcinomaSeminars in Cancer Biology, 2000